Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Dual inhibition of proteasomal and lysosomal proteolysis ameliorates autoimmune central nervous system inflammation.
Microglia Ontology and Signaling.
Neurogenic bowel dysfunction (NBD) translation and linguistic validation to classical Arabic.
Utilization of Dimethyl Fumarate and Related Molecules for Treatment of Multiple Sclerosis, Cancer, and Other Diseases.
[Expression of chemokine like factor-like myelin and lymphocyte and related proteins for vesicle trafficking and membrane link transmembrane domain-containing protein 2 in rats with varicocele].
Chronic inflammatory demyelinating polyneuropathy associated with manic symptoms.
Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis risk.
Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients.
Calcium Signalling Triggered by NAADP in T Cells Determines Cell Shape and Motility During Immune Synapse Formation.
Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis.
Pathologic and Protective Roles for Microglial Subsets and Bone Marrow- and Blood-Derived Myeloid Cells in Central Nervous System Inflammation.
Intravenous immunoglobulin in paediatric neurology: safety, adherence to guidelines, and long-term outcome.
Dyschromatopsia in Multiple Sclerosis Patients: A Marker of Subclinical Involvement?
5-Hydroxymethylcytosine Remodeling Precedes Lineage Specification during Differentiation of Human CD4(+) T Cells.
Preventing the BDNF and NGF loss involved in the effects of cornel iridoid glycoside on attenuation of experimental autoimmune encephalomyelitis in mice.
Novel pathologic findings in patients with Pelizaeus-Merzbacher disease.
The effects of fatigue, depression and the level of disability on the health-related quality of life of glatiramer acetate-treated relapsing-remitting patients with multiple sclerosis in Hungary.
High glucocorticoid levels during gestation activate the inflammasome in hippocampal oligodendrocytes of the offspring.
Evidence of Hepatitis E virus breaking through the blood-brain barrier and replicating in the central nervous system.
Effect of Fingolimod-Treatment on Blood Lipid Profiles of Multiple Sclerosis Patients.
An idiopathic thrombocytopenic purpura with polyneuropathy.
Perturbed cholesterol homeostasis in aging spinal cord.
Variations in multiple sclerosis practice within Europe - Is it time for a new treatment guideline?
Multi-Parametric Non-Negative Matrix Factorization for Longitudinal Variations Detection in White Matter Fiber-Bundles.
Neuroimmunology of a natural disaster.
Pages
« first
‹ previous
…
809
810
811
812
813
814
815
816
817
…
next ›
last »